Loading
Healthstream Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by McQuigg Michael Scott, was filed 24 Feb 2022.
Insider Decl.
656
Thresholds
n/a
Buy Volume
€282,492
5 ops. · all time
Sell Volume
€10M
40 ops. · all time
Who traded when
BuySaleKevin P. O'Hara2 sales
Fenstermacher Scott1 sale
Jeff Cunningham1 sale
Linda Rebrovick1 sale
ROBERT A. FRIST Jr.1 sale
Tate Deborah Taylor1 sale
Since the insiders bought
- +27.9%Entry US$19.83 · Close at T+365 US$25.37
- -1.6%Entry US$25.39 · Close at T+365 US$24.99
- -25.9%Entry US$25.87 · Close at T+365 US$19.18
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Healthstream Inc Buy (bullish), based on 3 analysts. Average price target: US$35.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 11,057 of 26,250 companies
55.6
score / 100
Value43
Quality68
FCF yld3.0%
Earn yld1.8%
EV/EBITDA16.3x
ROE6.0%
Gross mgn65%
Net mgn6.0%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$33.51
Analyst consensus
3 analystsBuy
US$29.00Target US$35.00(+4%)US$40.00
Income statement
RevenueUS$304.1M
Gross profitUS$196.9M65% margin
EBITDAUS$63.7M21% margin
Net incomeUS$18.3M6.6% margin
Valuation
PER (trailing)46.5x
PER (forward)37.9x
P/Book2.7x
Beta0.42
Balance sheet & cash
Market capUS$1B
Total debtUS$14.7M
Free Cash FlowUS$31.2M
Debt / Equity4%
Profitability & ownership
ROE6.0%
ROA3.2%
% insiders29.5%
% institutions76.7%
Last declaration on 23 October 2026
Declarations656 total
12,000 shares@ US$35.00Common StockSEC:0001437749-26-033424:0
1,955 shares0Common StockSEC:0001437749-26-031490:0
477 shares@ US$29.100.0016% mcap27.1% of flowCommon StockSEC:0001437749-26-031490:1
1,564 shares0Common StockSEC:0001437749-26-031492:0
1,955 shares0Common StockSEC:0001437749-26-031494:0
391 shares0Common StockSEC:0001437749-26-031496:0
1,564 shares0Common StockSEC:0001437749-26-031498:0
381 shares0Common StockSEC:0001437749-26-031498:1
134 shares@ US$29.100.0004% mcap100.0% of flowCommon StockSEC:0001437749-26-031496:1
381 shares@ US$29.100.0012% mcap100.0% of flowCommon StockSEC:0001437749-26-031502:1
477 shares@ US$29.100.0016% mcap0.3% of flowCommon StockSEC:0001437749-26-031494:1
1,642 shares0Common StockSEC:0001437749-26-031500:0
400 shares@ US$29.100.0013% mcap5.8% of flowCommon StockSEC:0001437749-26-031500:1
1,564 shares0Common StockSEC:0001437749-26-031502:0
1,642 shares0Common StockSEC:0001437749-26-031488:0
400 shares@ US$29.100.0013% mcap5.0% of flowCommon StockSEC:0001437749-26-031488:1
381 shares@ US$29.100.0012% mcap18.3% of flowCommon StockSEC:0001437749-26-031492:1
144,068 shares@ US$29.500.40% mcap94.4% of flowCommon StockSEC:0001437749-26-030481:0
6,000 shares@ US$29.000.020% mcap75.8% of flowCommonSEC144:0001969223-26-000765
1,249 sharesCommon Stock HoldingSEC:0001437749-26-020002:0
3,148 sharesCommon Stock HoldingSEC:0001437749-26-020001:0
3,148 sharesCommon Stock HoldingSEC:0001437749-26-019995:0
3,148 sharesCommon Stock HoldingSEC:0001437749-26-019996:0
3,148 sharesCommon Stock HoldingSEC:0001437749-26-019997:0
3,148 sharesCommon Stock HoldingSEC:0001437749-26-019998:0
25 of 656 declarations
About Healthstream Inc
Robert A. Frist Jr. is the name that recurs in Healthstream Inc's record: a EUR 3,666,480 sale on September 14, 2026, filed as CEO and Chairman, and the two largest purchases, EUR 103,329 on May 4, 2021 and EUR 82,280 on May 3, 2021, then CEO. Frist signs 51 filings, 2 of them purchases and 1 a sale. Frank Gordon (Director) bought EUR 44,218 on November 18, 2021. In all, 5 purchases weigh EUR 282,492 (median EUR 44,218), or 11% of open-market trades.
The 39 sales total EUR 9.9 million (median EUR 164,726). After Frist's, the largest are Linda Rebrovick's (Director), EUR 409,289 on March 7, 2018, and Michael Sousa's (Executive Vice President), EUR 377,771 on February 26, 2024.
Read moreShow less
The record holds 655 filings from February 22, 2016 to September 29, 2026, with a doubling of pace toward the end: 31 in 2016, 100 in 2024 and 100 in 2025. Michael Manning Collier (Executive Vice President) signs 57 with no open-market trade; Trisha L. Coady 49 and Jeff Cunningham (Chief Technology Officer) 43. There are 337 option exercises and 242 grants. The US healthcare and pharma company is worth USD 1.02 billion, and insiders hold 29.5%. Last twelve months: 84 filings, 4 sales. The median publication delay is 1 day.
